The Challenge of Creating Evidence-Based Clinical Practice Guidelines for the Use of Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Malignancies
Excerpt
The management of primary and secondary malignancies of the peritoneum continues to pose a challenge to modern, multidisciplinary cancer care.[...]
Share and Cite
Knapp, G.C.; Mack, L.A. The Challenge of Creating Evidence-Based Clinical Practice Guidelines for the Use of Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Malignancies. Curr. Oncol. 2020, 27, 125-126. https://doi.org/10.3747/co.27.6679
Knapp GC, Mack LA. The Challenge of Creating Evidence-Based Clinical Practice Guidelines for the Use of Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Malignancies. Current Oncology. 2020; 27(3):125-126. https://doi.org/10.3747/co.27.6679
Chicago/Turabian StyleKnapp, G.C., and L.A. Mack. 2020. "The Challenge of Creating Evidence-Based Clinical Practice Guidelines for the Use of Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Malignancies" Current Oncology 27, no. 3: 125-126. https://doi.org/10.3747/co.27.6679
APA StyleKnapp, G. C., & Mack, L. A. (2020). The Challenge of Creating Evidence-Based Clinical Practice Guidelines for the Use of Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Malignancies. Current Oncology, 27(3), 125-126. https://doi.org/10.3747/co.27.6679
